Polymorphisms (45TT, 276GT/TT) in the gene encoding adiponectin, involved in hepatic and peripheral glucose metabolism, independently predict liver disease severity in NASH by hepatic steatosis and necro-inflammatory grade along with postprandial adiponectin levels [38]. This evidence concerns the gene ADIPOQ and liver disorder.